Sofia 2 Lyme FIA Whole Blood Clinical Study

Completed

Conditions studied: Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)

In brief

The objective of this study is to demonstrate the clinical performance of the Sofia® 2 analyzer and Sofia Lyme FIA test in the CLIA waived test environment in comparison to Comparator Method(s) and/or an FDA cleared predicate test(s) using matched finger-stick, whole blood and serum from symptomatic subjects.

Key facts

Study ID
NCT03238274
Run by
Quidel Corporation
People needed
597
Starts
2017-06-06
Expected to finish
2017-12-15
Last updated by the study team
2018-03-20

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.